Earnings per Share (EPS) (Basic): A company's net earnings or losses attributable to common shareholders per basic share basis.
Indaptus Therapeutics, Inc. (INDP) had Earnings per Share (EPS) (Basic) of $-0.23 for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-2.54M |
|
-- |
|
-- |
|
$2.16M |
|
$-2.16M |
|
$-0.38M |
|
$-2.54M |
|
$-2.54M |
|
$-2.54M |
|
$-2.54M |
|
$-2.54M |
|
$-2.54M |
|
$-2.16M |
|
$-2.16M |
|
10.96M |
|
10.96M |
|
|
Earnings per Share (EPS) (Basic) |
$-0.23 |
$-0.23 |
|
| Balance Sheet Financials | |
$2.18M |
|
-- |
|
-- |
|
$2.18M |
|
$0.93M |
|
-- |
|
-- |
|
$0.93M |
|
$1.25M |
|
$1.25M |
|
$1.25M |
|
113.24M |
|
| Cash Flow Statement Financials | |
$-7.01M |
|
-- |
|
-- |
|
$8.51M |
|
$1.50M |
|
$-7.01M |
|
$0.23M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.34 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-7.01M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-203.63% |
|
-203.63% |
|
-116.52% |
|
-203.63% |
|
$0.01 |
|
$-0.64 |
|
$-0.64 |
|